DK482685D0 - Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme - Google Patents

Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme

Info

Publication number
DK482685D0
DK482685D0 DK482685A DK482685A DK482685D0 DK 482685 D0 DK482685 D0 DK 482685D0 DK 482685 A DK482685 A DK 482685A DK 482685 A DK482685 A DK 482685A DK 482685 D0 DK482685 D0 DK 482685D0
Authority
DK
Denmark
Prior art keywords
micellular
tumors
chemotherapeutic agents
micellular particles
particles
Prior art date
Application number
DK482685A
Other languages
Danish (da)
English (en)
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Raymond Leo Teplitz
Lawrence Ernest Williams
George Wing-Yiu Tin
Original Assignee
Hope Nat Medical Center
Vestar Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/663,550 external-priority patent/US5441745A/en
Priority claimed from US06/663,503 external-priority patent/US5435989A/en
Application filed by Hope Nat Medical Center, Vestar Research Inc filed Critical Hope Nat Medical Center
Publication of DK482685D0 publication Critical patent/DK482685D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK482685A 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme DK482685D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/663,550 US5441745A (en) 1982-03-30 1984-10-22 Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US06/663,503 US5435989A (en) 1982-03-30 1984-10-22 Method of targeting a specific location in a body

Publications (1)

Publication Number Publication Date
DK482685D0 true DK482685D0 (da) 1985-10-21

Family

ID=27098764

Family Applications (2)

Application Number Title Priority Date Filing Date
DK482685A DK482685D0 (da) 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
DK484585A DK167556B1 (da) 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK484585A DK167556B1 (da) 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller

Country Status (11)

Country Link
EP (1) EP0179444B1 (fr)
JP (1) JPH0747533B2 (fr)
KR (1) KR900004802B1 (fr)
AT (1) ATE64298T1 (fr)
CA (1) CA1298548C (fr)
DE (2) DE19675031I2 (fr)
DK (2) DK482685D0 (fr)
HK (1) HK119993A (fr)
IE (1) IE58659B1 (fr)
LU (1) LU88811I2 (fr)
NL (1) NL960020I1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5648532A (en) * 1993-06-03 1997-07-15 The Regents Of The University Of California Compositions for boron neutron capture therapy and methods thereof
DE19606326A1 (de) * 1995-02-09 1996-08-22 Schering Ag Kontrastmittelhaltige Liposomenformulierung sowie deren Verwendung für die In-vivo-Diagnostik, insbesondere für die Darstellung des Intravasalraumes
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
JP2007512221A (ja) * 2003-11-21 2007-05-17 富士フイルム株式会社 疎水性キレート化合物を含有するリポソームを含む造影剤
EP1745788A1 (fr) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipides pour le traitement du cancer et de la cachexie
JP5936002B2 (ja) * 2010-11-19 2016-06-15 北海道公立大学法人 札幌医科大学 組合わせ医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
JPS59122423A (ja) * 1982-12-28 1984-07-14 Green Cross Corp:The 制癌剤含有脂肪乳剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム

Also Published As

Publication number Publication date
KR900004802B1 (ko) 1990-07-06
JPS61158932A (ja) 1986-07-18
EP0179444A3 (en) 1987-08-12
EP0179444A2 (fr) 1986-04-30
KR860003514A (ko) 1986-05-26
JPH0747533B2 (ja) 1995-05-24
EP0179444B1 (fr) 1991-06-12
CA1298548C (fr) 1992-04-07
DK484585A (da) 1986-04-23
DK167556B1 (da) 1993-11-22
DE19675031I2 (de) 2008-04-10
IE58659B1 (en) 1993-11-03
DK484585D0 (da) 1985-10-22
IE852602L (en) 1986-04-22
LU88811I2 (fr) 1996-11-05
ATE64298T1 (de) 1991-06-15
NL960020I1 (nl) 1996-11-01
HK119993A (en) 1993-11-12
DE3583204D1 (de) 1991-07-18

Similar Documents

Publication Publication Date Title
EP0430968A4 (en) Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
ES8304797A1 (es) "procedimiento para la preparacion de nuevas formas orales de dipiridamol, en forma de granulados, pastillas o tabletas".
DK482685D0 (da) Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
AU4515985A (en) New tetrapyrrole therapeutic agents
ES8500743A1 (es) Procedimiento para preparar formas de mopidamol como granulados, granulos o tabletas
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
WO1992017159A3 (fr) Compositions emulsionnees stabilisees destinees a donner a leur peau humaine un hale artificiel
EP0637246A4 (fr) Procedes de traitement du cancer au moyen de la proteine c-reactive.
DE3472406D1 (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
HUT39433A (en) Process for producing alpha-aryl-4-/4,5-anhydro-3,5-dioxo-1,2,4-triazin-2/3h/-yl/-phenylacetonitriles and pharmaceutical compositions containing them as active agents
ES8708220A1 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
BG103729A (en) New derivatives of carboxylic acids, their preparation and administration for cancer treatment
PL344414A1 (en) Combination therapy for the treatment of tumors
AU1988383A (en) Composition for treating myocardial infarction
ATE70456T1 (de) Verwendung von micellaren partikeln zur herstellung von zusammensetzungen zum beschiessen von tumoren in menschen und deren verwendung.
AU5731386A (en) 99mTc(III) myocardial imaging agents which are non-reducable in vivo
DE3465014D1 (en) Podophyllotoxin preparations for use in the treatment of genital warts
JOHNSON et al. 5 Histopathology and Histochemistry of Cutaneous Calciphylaxis
Domańska‐Janik et al. Effects of anoxia and depolarization on the movement of carbon atoms derived from glucose into macromolecular fractions in rat brain slices
Abroyan Ion Microbeam Analysis of the Phase Composition of Thin Layers of Silicon Alloyed With Phosphorus by Ion Implantation
Ainsworth et al. LATE EFFECTS OF HIGH LINEAR-ENERCY-TRANSFER (LET) RADIATIONS
Zolotov Extraction of Metals by Certain Sulphur--Nitrogen-Containing Macrocyclic Compounds

Legal Events

Date Code Title Description
ATS Application withdrawn